Abstract:Ethnopharmacological relevance: Inflammatory bowel disease (IBD) presents a risk of carcinogenesis, which escalates with the duration of IBD. Persistent histological inflammation is considered to be the driving factor of colitis carcinogenesis. Effective control of inflammation is helpful to prevent and treat colitis-related colorectal cancer (CAC). Anchang Yuyang Decoction (AYD), a traditional Chinese medicine (TCM) formula, is originated from the ancient prescription of TCM for treating colitis and colorectal cancer. AYD has demonstrated efficacy in treating IBD and potential anti-carcinogenic properties. Aim of the study: This research aims to assess the therapeutic efficacy of AYD in ameliorating experimental colitis-related carcinogenesis induced by AOM/DSS. It further seeks to elucidate its potential mechanisms by integrating multiple omics sequencing approaches. Materials and methods: A rat model for colitis-related carcinogenesis was developed using azoxymethane (AOM)/dextran sulfate sodium (DSS). UPLC-MS identified AYD's chemical constituents. Rats were administered varying doses of AYD (18.37, 9.19 and 4.59 g/kg) orally for 53 days, with mesalazine as a positive control. The study evaluated anti-carcinogenic effects by examining adenoma number, adenoma load, abnormal crypt foci (ACF), histopathological damage, and tumor-related protein expression. Anti-inflammatory and reparative effects were assessed through body weight, disease activity index (DAI), colon length, spleen index, inflammatory cytokine levels, and tight junction protein expression. The effects on intestinal microbiota and host metabolism were explored through 16S rRNA sequencing, targeted short-chain fatty acid (SCFA) metabonomics, and non-targeted colon metabolomics. Potential AYD targets were identified through transcriptomic sequencing and validated by qRT-PCR and western blotting. Results: AYD significantly reduced adenoma number, adenoma load, neoplasm-associated lesions, ACF, and tumor-related protein expression (e.g., p53, PCNA) in AOM/DSS-induced rats, thus impeding colitis-related carcinogenesis progression. AYD also alleviated histopathological damage and inflammation, promoting intestinal mucosal barrier repair. Furthermore, AYD modulated intestinal flora structure, enhanced SCFA production, and regulated colon metabolites. Transcriptomic sequencing revealed a significant impact on the peroxisome proliferator-activated receptor (PPAR) signaling pathway. Subsequent qRT-PCR and western blotting experiments indicated AYD's influence in up-regulating PPAR-γ and down-regulating PPAR-α, PPAR-β/δ, and related proteins (thrombomodulin [Thbd], fatty acid binding protein 5 [Fabp5], stearoyl-CoA desaturase 2 [Scd2], phospholipid transfer protein [Pltp]). Conclusions: This study demonstrates AYD's ability to inhibit experimental colitis-related carcinogenesis induced by AOM/DSS. Its mechanism likely involves modulation of the PPAR signaling pathway, impacting intestinal microbiota and host metabolic equilibrium.

Apple Polysaccharide Reduces Nf-Kb Mediated Colitis-Associated Colon Carcinogenesis

Apple Polysaccharide Prevents from Colitis-Associated Carcinogenesis Through Regulating Macrophage Polarization.

Apple Polysaccharides Induce Apoptosis in Colorectal Cancer Cells.

Apple Polysaccharide Protects ICR Mice Against Colitis Associated Colorectal Cancer Through the Regulation of Microbial Dysbiosis.

Modified Apple Polysaccharide Prevents Colitis Through Modulating IL-22 and IL-22BP Expression.

Modified Apple Polysaccharides Suppress the Migration and Invasion of Colorectal Cancer Cells Induced by Lipopolysaccharide

Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention

An Apple Oligogalactan Prevents Against Inflammation and Carcinogenesis by Targeting LPS/TLR4/NF- B Pathway in a Mouse Model of Colitis-Associated Colon Cancer

An Apple Oligogalactan Suppresses Endotoxin-Induced Cyclooxygenase-2 Expression by Inhibition of LPS Pathways.

Modified Apple Polysaccharides Could Induce Apoptosis in Colorectal Cancer Cells

Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats.

Modified Apple Polysaccharide Influences MUC-1 Expression to Prevent ICR Mice from Colitis-Associated Carcinogenesis.

Low Molecular Weight Apple Polysaccharides Induced Cell Cycle Arrest in Colorectal Tumor

Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated Cancer

Albuca Bracteata Polysaccharides Attenuate AOM/DSS Induced Colon Tumorigenesis via Regulating Oxidative Stress, Inflammation and Gut Microbiota in Mice

Apple Polyphenol Extract Suppresses Clostridioides difficile Infection in a Mouse Model

The Inhibitory Effect of Polysaccharide from Rhizopus Nigricans on Colitis-Associated Colorectal Cancer.

Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota

Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model

Tea Polysaccharide Prevents Colitis-Associated Carcinogenesis In Mice By Inhibiting The Proliferation And Invasion Of Tumor Cells

Apple Polyphenols Extract (APE) Alleviated Dextran Sulfate Sodium Induced Acute Ulcerative Colitis and Accompanying Neuroinflammation via Inhibition of Apoptosis and Pyroptosis